LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Glucagon-like peptide-1 (GLP-1) receptor agonists are temperature-sensitive biological medications requiring careful storage to maintain efficacy. Unopened GLP-1 pens stored correctly in the refrigerator at 2°C to 8°C remain stable until their printed expiry date. Once opened or removed from refrigeration, storage durations vary by product—ranging from 14 days to 6 weeks depending on the specific brand. Understanding proper storage requirements is essential for patients using semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), tirzepatide (Mounjaro), and other GLP-1 formulations to ensure optimal therapeutic outcomes and medication safety.
Quick Answer: Unopened GLP-1 medications stored at 2°C to 8°C remain stable until their expiry date, whilst opened pens last 14 days to 6 weeks depending on the specific product.
Glucagon-like peptide-1 (GLP-1) receptor agonists are temperature-sensitive biological medications that require careful storage to maintain their therapeutic efficacy. When stored correctly in the refrigerator at temperatures between 2°C and 8°C, unopened GLP-1 medications typically remain stable until their printed expiry date, which varies by product.
Storage requirements after opening or removal from refrigeration vary by brand:
Semaglutide (Ozempic) multi-dose pens can be used for up to 6 weeks after first use, whether kept refrigerated or at room temperature (below 30°C).
Semaglutide (Wegovy) single-use pens may be stored at temperatures up to 30°C for up to 6 weeks before use.
Dulaglutide (Trulicity) single-use pens may be kept at temperatures up to 30°C for up to 14 days before use.
Liraglutide (Victoza, Saxenda) multi-dose pens may be kept for 1 month after opening, whether refrigerated or at room temperature (below 30°C).
Exenatide (Byetta) can be stored for 30 days after first use at temperatures up to 25°C.
Lixisenatide (Lyxumia) can be stored for 14 days after first use at temperatures up to 30°C.
Tirzepatide (Mounjaro) single-use pens may be stored at temperatures up to 30°C for up to 21 days before use.
Oral semaglutide (Rybelsus) tablets do not require refrigeration and should be stored at room temperature.
It is essential to consult the patient information leaflet supplied with your specific medication, as storage durations differ between products. The MHRA-approved product characteristics provide definitive guidance for each formulation. Never use a GLP-1 medication beyond its expiry date or recommended in-use period, even if it has been continuously refrigerated, as the active ingredient may degrade and lose potency.
Patients using multi-dose pens should write the date of first use on their pen to track how long it has been in use. If you are uncertain whether your medication has been stored correctly or for how long, contact your community pharmacist or prescribing clinician for advice before administering the dose.
Correct storage of GLP-1 receptor agonists is critical to preserve the structural integrity of these peptide-based medications. Unopened pens and cartridges must be stored in their original packaging in a refrigerator at 2°C to 8°C. The original carton protects the medication from light exposure, which can degrade the active pharmaceutical ingredient.
Key storage principles include:
Never freeze or shake GLP-1 medications – freezing irreversibly damages the protein structure. If a pen has been frozen, it must be discarded, even if it subsequently thaws.
Store away from the freezer compartment – place pens in the main body of the refrigerator, not in the door or near cooling elements where temperatures may fluctuate.
Keep the pen cap on when not in use to protect from light and reduce contamination risk of the needle attachment site.
Do not store with the needle attached – remove and safely dispose of needles after each injection to prevent medication leakage, air bubbles, and contamination.
Once in use, most GLP-1 medications may be stored at room temperature for the manufacturer's specified duration. The exact temperature limit (typically ≤25°C or ≤30°C) and allowable duration vary by product, so check your specific product leaflet or SmPC. This flexibility facilitates daily use without repeated refrigerator access. However, the medication should be kept away from direct heat sources, such as radiators, windowsills with direct sunlight, or vehicle glove compartments.
For patients using multi-dose pens, maintaining a consistent storage location—either refrigerated or at controlled room temperature—helps establish routine and reduces the risk of storage errors. Single-use pens (such as Wegovy, Trulicity, and Mounjaro) have different storage requirements than multi-dose pens, so follow the specific guidance for your product.
Always store medications out of reach of children and never transfer GLP-1 solution to another container, as this compromises sterility and accurate dosing.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Improper storage of GLP-1 medications can compromise their therapeutic effectiveness and safety. These biological products contain peptide molecules that are susceptible to degradation when exposed to temperatures outside the recommended range. When GLP-1 receptor agonists are stored incorrectly, the three-dimensional protein structure may become denatured, reducing or eliminating the medication's ability to bind to GLP-1 receptors and exert its glucose-lowering and weight-management effects.
Freezing is particularly damaging. If a GLP-1 pen has been frozen—even briefly—the medication must be discarded immediately. Frozen and thawed peptide solutions may appear normal but have undergone irreversible structural changes. Using such medication may result in inadequate glycaemic control in patients with type 2 diabetes or reduced efficacy for weight management indications.
Exposure to excessive heat (above the product-specific temperature limit for extended periods) similarly degrades the active ingredient. Patients may not achieve expected HbA1c reductions or weight loss outcomes if using heat-damaged medication. Efficacy cannot be assured if storage conditions are breached, and the medication should not be used.
Visual inspection is important but not definitive. Before each injection, examine the solution through the pen window. It should be clear and colourless (or almost colourless). Do not use the medication if it appears cloudy, discoloured, contains particles, or if the consistency has changed. However, some degradation may not be visible, which is why adherence to storage guidelines is essential.
If you suspect your GLP-1 medication has been stored incorrectly—for example, left out overnight, exposed to heat during a heatwave, or potentially frozen—contact your community pharmacist immediately. Do not use the medication until you receive professional guidance. Your pharmacist can advise and contact your prescriber to arrange a replacement if appropriate.
If you experience unexpected side effects or issues with your GLP-1 medication or delivery device, report these through the MHRA Yellow Card scheme.
Travelling with GLP-1 medications requires advance planning to maintain appropriate storage conditions throughout your journey. For short trips within the UK, most GLP-1 receptor agonists can be safely transported at room temperature for their specified product-dependent duration, provided they are protected from temperature extremes.
For air travel, carry your GLP-1 medication in your hand luggage rather than checked baggage, as cargo holds may experience freezing temperatures. Bring your prescription or a letter from your GP confirming your need for the medication and injection devices, as airport security may require documentation. UK Civil Aviation Authority and airline regulations permit passengers to carry necessary medical supplies, including needles and syringes, when accompanied by supporting documentation. Check with your specific airline before travelling.
Use an insulated medication travel case to protect your GLP-1 pen from temperature fluctuations. Whilst these cases are not refrigerated, they provide thermal protection against ambient heat and cold. For longer journeys or travel to hot climates, consider using cooling wallets or pouches specifically designed for insulin and other temperature-sensitive medications. These typically maintain temperatures within the safe range for 12–48 hours, depending on the product.
Avoid using ice packs directly against the medication, as this may cause localised freezing. If using cooling elements, ensure there is a barrier (such as fabric) between the ice pack and the medication pen. Never store GLP-1 medications in hotel minibars that may freeze, or leave them in vehicles where temperatures can rapidly exceed safe limits.
For extended international travel, research refrigeration access at your destination. Many hotels can provide refrigerator access upon request for medical storage. If travelling to remote areas without reliable refrigeration, consult your pharmacist about the maximum duration your specific GLP-1 product can remain at room temperature, and plan your medication supply accordingly. Some patients may need to adjust their travel schedule or arrange for refrigerated storage through local pharmacies or medical facilities at their destination.
Knowing when to discard GLP-1 medication is essential for patient safety and treatment efficacy. Several circumstances require immediate disposal of your GLP-1 pen, regardless of how much medication remains.
Mandatory disposal situations include:
Expiry date reached – never use medication beyond the printed expiry date, even if unopened and continuously refrigerated.
In-use time limit exceeded – once opened, multi-dose GLP-1 pens must be discarded after the manufacturer's specified duration (typically 14 days to 6 weeks), even if doses remain. For single-use pens, discard after use or if the out-of-refrigerator time limit is exceeded before use.
Freezing has occurred – any exposure to freezing temperatures requires immediate disposal.
Visible contamination or damage – discard if the solution appears cloudy, discoloured, contains particles, or if the pen is cracked or damaged.
Storage temperature exceeded – if the medication has been exposed to temperatures above the product-specific limit (check your leaflet/SmPC) for extended periods, it should be discarded.
Uncertain storage history – if you cannot confirm the medication has been stored correctly, err on the side of caution and obtain a replacement.
Proper disposal is important for environmental and safety reasons. Used GLP-1 pens should be disposed of according to local NHS guidelines. Most community pharmacies operate medication take-back schemes where you can return used pens and needles in appropriate sharps containers. Never dispose of medication in household waste or down drains, as this may contaminate water supplies.
For needle disposal, use an approved sharps bin (available on prescription from your GP or via local authority schemes; check local arrangements). When the container is three-quarters full, seal it and return it to your pharmacy or local authority collection point. Never recap needles or dispose of them in regular bins, as this poses injury and infection risks to waste handlers.
If you need to discard medication before its expiry due to storage concerns or adverse effects, inform your prescriber. They can assess whether an alternative GLP-1 formulation or different medication class may be more suitable for your circumstances. Maintaining open communication with your healthcare team ensures optimal diabetes management or weight loss outcomes whilst minimising medication waste.
If you experience any suspected side effects or issues with your GLP-1 medication or pen device, report these through the MHRA Yellow Card scheme.
Most GLP-1 medications can be stored at room temperature for product-specific durations (14 days to 6 weeks), so a single overnight period is typically acceptable if within this timeframe. However, if you are uncertain about storage duration or conditions, contact your community pharmacist for guidance before using the medication.
Discard any GLP-1 medication that has been frozen, even if it subsequently thaws and appears normal. Freezing irreversibly damages the protein structure, rendering the medication ineffective and potentially unsafe.
Return used or expired GLP-1 pens to your community pharmacy through NHS medication take-back schemes. Dispose of needles in an approved sharps container, which should be returned to your pharmacy or local authority collection point when three-quarters full.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
